CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,800 shares at $13.51 ($51,338)
- 4 Grant or award Co-Chief Executive Officer acquired 248,865 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 74,660 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 95,990 shares (grant or award)
- 4 Grant or award Co-Chief Executive Officer acquired 248,865 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 95,990 shares (grant or award)
- 4 Open-market sale Co-Chief Executive Officer sold 29,282 shares at $14.47 ($423,760)
- 4 Open-market sale Co-Chief Executive Officer sold 29,282 shares at $14.48 ($424,120)
- 4 Open-market sale Chief Medical Officer sold 6,461 shares at $14.58 ($94,205)
- 4 Open-market sale Chief Financial Officer sold 7,909 shares at $14.52 ($114,851)
- 4 Open-market sale Chief Legal Officer sold 6,844 shares at $14.52 ($99,378)
- 4 Open-market sale Chief Legal Officer sold 3,419 shares at $14.14 ($48,352)
- 4 Open-market sale Chief Financial Officer sold 3,557 shares at $14.65 ($52,097)
- 4 Open-market sale Co-Chief Executive Officer sold 15,500 shares at $14.68 ($227,593)
- 4 Open-market sale Chief Legal Officer sold 3,448 shares at $14.65 ($50,516)
- 4 Open-market sale Co-Chief Executive Officer sold 15,500 shares at $14.69 ($227,618)
- 4 Open-market sale Co-Chief Executive Officer sold 138,167 shares at an average $13.59 ($1,878,094)
- 4 Open-market sale Co-Chief Executive Officer sold 138,188 shares at an average $13.59 ($1,877,570)
- 4 Gift Director gave 17,780 shares (gift)
Page 2 of 11 · 207 filings